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The fragile X syndrome: 
Isolation of the FMR-1 gene 
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of the fragile X mutation 
Ben A. Oostra* and Annemieke J.M.H. Verkerk** 
Fragile J( syndrome, associated with the fragile X chromo- 
some, is the most common cause o f familial mental retar- 
dation. A breakthrough as been made in molecular bio- 
logical research into the fragile X site. In this review we 
describe the molecular investigations that have led to the 
isolation of the FMR-1 gene. The nature of the fragile 
J[ mutation as well as the implications of the DNA test 
for the mutation are discussed. 
Introduction 
Inherited forms of mental retardation that result from 
defects on the X chromosome affect 1/500 males and 
leave about 1/200 females at risk of being carriers (Opitz 
and Sutherland 1984). To determine whether the same 
form of X-linked mental retardation is present in two 
or more unrelated families, there must be a good charac- 
terization of the phenotype, which is found in all males. 
Genetic studies of families with the same phenotype will 
determine the chromosomal localization of the disease, 
followed by the search for the gene and the mutation. 
In this paper we review the research on fragile X syn- 
drome, the search for the gene and the mutation causing 
the phenotype. 
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Description of fragile X syndrome 
In 1943, Martin and Bell (1943) described the first pedi- 
gree clearly demonstrating an X-linked form of mental 
retardation. In metaphases of cells from Martin-Bell syn- 
drome patients a fragile site was noted at the tip of 
the long arm of the X chromosome (Lubs 1969). The 
fragile sites appear as an unstained gap or break at a 
defined point on the X chromosome and are inherited 
in a Mendelian fashion. More than 64 other fragile sites 
have been described, but none of these other sites has 
been linked to a genetic disease (Sutherland and Ledbet- 
ter 1989). 
The phenotype of the fragile X syndrome is mental 
retardation, usually with an IQ in the 40-70 range (Suth- 
erland and Hecht 1985; Fish et al. 1991), and a number 
of dysmorphic features: long face, large everted ears and 
large testicles. Not every patient shows all the physical 
symptoms, which are generally more apparent after 
childhood. The fragile X syndrome is the most frequent- 
ly encountered form of inherited mental retardation in 
humans, with a prevalence stimated to be 1 in 1,250 
males (Gustavson et al. 1986; Webb et al. 1986). Distinc- 
tion between the fragile X syndrome and other forms 
of X-linked mental retardation is based on the identifica- 
tion of the fragile site at Xq27.3 in cultured lymphocytes, 
fibroblasts and amniocytes (Opitz and Sutherland 1984; 
Sutherland 1977). The exact mechanism underlying frag- 
ile site expression is unknown, but it appears to involve 
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Fig. 1. Chromosome preparation f normal and fragile X chromo- 
some 
the availability of DNA synthetic precursors. Adequate 
concentrations of thymidine and/or cytidine are neces- 
sary. Fragile X expression is obtained by culturing cells 
in medium deficient in folic acid and thymidine or with 
excess thymidine (Sutherland and Baker 1986; Jacky 
et al. 1991), with 2% to 60% of the cells examined ex- 
pressing the fragile site (Fig. 1). The frequency of fragile 
X positive cells seems to be somewhat characteristic of
an individual. Although affected males virtually always 
express the fragile site, only about 50% of obligate carri- 
er females can be detected using this test (Nielsen et al. 
1983). The cytogenetic test is not reliable in detecting 
clinically normal carriers, a fact that has limited its value 
in genetic ounselling. 
Genetics 
The fragile X syndrome shows unusual genetic harac- 
teristics. About one-third of carrier females are mentally 
retarded but they are often less severely affected than 
males. One most unusual feature for an X-linked dis- 
order is the existence of normal carrier males. In the 
original family described by Martin and Bell (1943) two 
unaffected brothers had passed on the gene for the frag- 
ile X syndrome through their healthy daughters to the 
following generations. Sherman et al. (1985) have shown 
that approximately 20% of males who are known on 
the basis of genealogic data to carry the fragile X chro- 
mosome are phenotypically normal but they can pass 
the trait on to their daughters, who are also asympto- 
matic. But members of the next generation are often 
mentally impaired. Sherman determined that the risk 
of having the phenotypic effect for individuals in fragile 
X families is dependent upon the position of the individ- 
ual in the pedigree (the so-called Sherman paradox). The 
grandsons of normal transmitting males have a risk of 
40% of intellectual handicap and great-grandsons are 
at 50% risk; brothers of normal transmitting males are 
at 9% risk. If the carrier mother has signs of the fragile 
X syndrome, the risk that the sons will be mentally han- 
dicapped becomes 50%. 
To explain these unique features everal models have 
been proposed. One model was put forward by Pembrey 
et al. (1985). A normal transmitting male would harbour 
a "premutation" on his X chromosome with no pheno- 
typic effects by itself. In a daughter this premutation 
could undergo meiotic recombination with an "enhanc- 
ing sequence" on the homologous region of the other 
X chromosome during oogenesis. Then a full mutation 
with phenotypic effects would be generated. The nature 
of this enhancing sequence on the normal chromosome 
is unidentified. The model predicts that recombination 
should be found systematically, which is clearly not the 
case; double recombinants have to be postulated. 
A second more attractive model put forward by Laird 
(1987) proposed a mechanism involving inheritance of 
fragile X based upon DNA methylation. A normal 
transmitting male carries an X chromosome with a (pre)- 
mutation without phenotypic effects. If this chromo- 
some is inactivated in the next generation as part of 
the process of dosage compensation i  females having 
two X chromosomes, the reactivation of this chromo- 
some is blocked in the fragile X region. DNA methyla- 
tion is presumed to be involved in X inactivation. The 
fragile X region has become imprinted: one or several 
genes in the vicinity of Xq27 are turned off. However, 
this does not appear to explain the altered segregation 
ratios of affected to unaffected offspring described by 
Sherman et al. (1985). 
Markers and linkage analysis 
The first DNA marker shown to be linked to the fragile 
locus was Factor 9 (Camerino et al. 1983). Although 
no recombination was seen in the large family described, 
several families were reported in which recombination 
was seen between F9 and the fragile X locus. Brown 
et al. (1985, 1988) noted differences between families 
with tight linkage of fragile X to F9 and families with 
a loose linkage; he suggested genetic heterogeneity as
a possible explanation for this discrepancy. This could 
not be confirmed by others (Suthers et al. 1991 a) and 
the apparent heterogeneity may reflect uncertainties due 
to limited statistics and mistyping of individuals in fami- 
lies. 
Several DNA markers were soon reported for the 
detection of loci close to the fragile X locus (Fig. 2A). 
Dahl et al. (1989) and Suthers et al. (1989) described 
clones U6.2 and VK21, which are located distal to the 
fragile site. On the proximal side clones RNI (Oostra 
et al. 1990) and VK23 (Suthers et al. 1991b) were ob- 
tained, which were placed by genetic mapping within 
5 cM of the fragile X syndrome locus. These flanking 
markers, spanning a region of 6-7 cM, have been very 
useful for carrier testing and prenatal diagnosis in a 
number of families (Suthers et al. 1991 b). More recently, 
a series of markers were isolated that were shown to 
map in this interval (Rousseau et al. 1991 a; Hirst et al. 
1991a; Hulsebos etal. 1991; Riggins et al. 1992) 
(Fig. 2A). The genetic mapping of these probes limited 
the region of the fragile site to 1 or 2 Mb. The markers 
closest o the fragile site were used as starting points 
for the isolation and characterization f the fragile X 
mutation. 
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Fig. 2A-C. Map of the fragile X 
region at Xq27.3. A Genetic map 
of DNA markers flanking the 
fragile site (FRAJO. B Partial 
physical map of YAC 209G4 
with the location of the FMR-I 
gene CpG island shown boxed. 
C Fragment containing CpG 
island, CGG repeat and exon of 
FMR-1. Schematic representation 
of hybrid cell lines micro 21D 
and Q1X (Warren et al. 1987) 
Molecular approaches to the isolation 
of the fragile X locus 
An approach to the isolation of the fragile X locus was 
the strategy designed by Warren et al. (1987). A somatic 
cell hybrid was isolated that contained a human X chro- 
mosome from a fragile X patient in a hamster back- 
ground. By culturing this cell line under conditions for 
induction of fragile X expression and selection for ex- 
pression of genes on either side of the fragile site, several 
somatic ell hybrids were isolated that contained translo- 
cations between human and hamster material. The inten- 
tion of these experiments was that the fragile site should 
be a preferential location for the occurrence of such 
translocation events. DNA marker analysis showed that 
the breakpoints coincide with a region close to or within 
the fragile site (Rousseau etal. 1991a; Hirst etal. 
1991 a). Efforts to clone these breakpoints directly into 
cosmids have not been successful; this is most likely 
caused by the sequence composition of the fragile X 
mutation. These hybrid cell lines have proved to be bene- 
ficial in the isolation of the fragile X locus, 
A different approach to the isolation of the fragile 
X region has been chromosome microdissection. The 
fragile X region was dissected from human metaphase 
chromosomes followed by cloning of the dissected DNA 
after amplification by polymerase chain reaction (PCR) 
methods (Mackinnon et al. 1990). A slightly different 
version of the technique was performed using laser mi- 
crodissection of X chromosomes displaying the fragile 
site (Djabali et al. 1991). A number of clones were iso- 
lated, two of which were shown to map in the 1 Mb 
interval around the fragile site (Mackinnon et al. 1990). 
Cloning of human DNA in yeast artificial chromo- 
somes (YACs) made it possible to isolate DNA frag- 
ments up to 1 Mb. YAC libraries became available from 
normal X chromosomes a well as from a fragile X chro- 
mosome. By using markers tightly linked to the fragile 
site YACs were isolated with insert sizes between 275 
and 520 kb (Heitz et al. 1991; Verkerk et al. 1991; 
Kremer et al. 1991 a; Hirst et al. 1991 b). The YACs con- 
tained breakpoints from the cell hybrids isolated by War- 
ren (1987), with breakpoints in the fragile region. Fluo- 
rescence in situ hybridization with these YAC clones 
was performed on metaphase chromosomes displaying 
the fragile site. Fluorescent signals were scored on the 
proximal and on the distal side of the (fragile) gap (Heitz 
et al. 1991; Verkerk et al. 1991; Kremer et al. 1991a; 
Hirst et al. 1991b; Verkerk et al. 1992) indicating that 
the YAC clones indeed span the fragile site (Fig. 3). Hy- 
bridization of a subclone of YAC 209G4 to a fragile 
X chromosome is shown on the cover. The fluorescent 
signal falls on the fragile site. The size of the fragile 
site has been suggested to be limited to less than 20 kb 
(Kremer et al. 1991 b; Verkerk et al. 1992). The presence 
of well-separated signals on both sides of the fragile site 
indicates that the DNA is locally highly unfolded, An- 
other explanation could be that a break has occurred 
in one of the chromatids. 
The FMR-1 gene and the nature of the fragile X mutation 
Physical studies of the distal region of the long arm 
of the X chromosome using pulsed field gel electrophore- 
sis (PFGE) disclosed that the fragile site is located ap- 
proximately 9 Mb from the telomere (Poustka et al. 
1991). Detailed PFGE mapping of the fragile X region 
showed that rare-cutter restriction sites (rich in CpG 
dinucleotide sequences) were resistant o digestion by 
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Fig. 3. Fluorescence in situ hybridization of YAC 209G4 (see 
Fig. 2) to a chromosome preparation from a fragile X patient. 
A centromere probe specific for the X chromosome confirmed the 
identity of the chromosome examined 
methylation sensitive restriction enzymes in fragile X 
males, but not in normal males (Vincent et al. 1991; 
Bell et al. 1991) (Fig. 2). Cytosine methylation of a CpG 
island containing a cluster of rare-cutter sites is indica- 
tive of the promoter region of a gene whose expression 
is subsequently shut off. Normal DNA methylation was 
observed on X chromosomes of normal transmitting 
males but abnormal methylation of the X chromosome 
was observed in their affected grandsons. This is in 
agreement with the proposed change in methylation 
after passage through a carrier female who shows a nor- 
mal methylation pattern (Laird 1987). A CpG island 
is localized on the YACs spanning the fragile site. 
Subclones of the sequences around the CpG island 
were used as probes and confirmed the abnormal methy- 
lation patterns in affected males (Oberl6 et al. 1991 ; Yu 
et al. 1991). Clones mapping adjacent to the CpG island 
detected a 550 bp DNA segment that was unstable in 
fragile X chromosomes. A small insertion (premutation) 
of 50 to 500 bp was detected in ormal transmitting 
males, which was inherited by their daughters. In the 
next generation fragile X positive individuals had much 
larger inserts (full mutation). The mutated allele ap- 
peared unmethylated in normal transmitting males and 
totally methylated in most fragile X positive males. The 
size increase was generally heterogeneous among siblings 
and even within a given individual, indicating somatic 
mutation. 
A different approach was taken by Verkerk et al. 
(1991). A cosmid clone from YAC 209G4 (Fig. 2), iden- 
tified overlapping clones from a fetal brain complemen- 
tary DNA (cDNA) library. The cDNA clone detects 
an mRNA of 4.4 kb, normally expressed in brain and 
other tissues; the corresponding gene was designated 
FMR-1 (fragile X mental retardation-l). A 5' exon of 
the gene contains a repetitive sequence (CGG)n that is 
located 250 bp from the CpG island showing specific 
methylation i fragile X patients (Fig. 2). In this CGG 
repeat are located a number of the breakpoints of the 
somatic cell hybrids with induced breakpoints in the 
fragile site (Kremer et al. 1991b; S. Warren, personal 
communication). The CpG island as well as the CGG 
repeat are located on a 5.2 kb EcoRI fragment (Fig. 2). 
In patients a dramatic expansion of this band is seen; 
often marked heterogeneity of the bands results in a 
diffuse smear (Fig. 4). In normal transmitting males and 
in daughters of transmitting males (lanes 1, 6 and 10) 
a small expansion of between 50 and 500 bp is observed. 
When this premutation passes through female meiosis 
it can either expand to a full mutation (lanes 2-4, 8 
and 9) or not expand, resulting in a normal transmitting 
male (lane 11). 
In lymphoblasts, leucocytes and fibroblasts of most 
fragile X males the FMR-1 gene is transcriptionally si- 
lent, suggesting direct involvement of this gene in the 
manifestation of the fragile X syndrome (Pieretti et al. 
1991). The loss of expression of the FMR-I gene corre- 
lates with methylation of the CpG island. It appears 
likely that the methylation of the region down-regulates 
FMR-1 expression resulting in the disease. In a few pa- 
tients expression of FMR-1 can be demonstrated. These 
patients how a mosaic DNA pattern with a near nor- 
mal-size band together with a smear of bands of in- 
creased size. Partial methylation of the CpG island is 
observed. Several explanations could account for the dis- 
crepancy of expression i  these patients. Firstly, is: the 
level of expression does not reach the necessary thresh- 
old to provide normal levels of protein. Secondly, 
mRNA expression does not necessarily assure a normal 
FMR-1 protein. Thirdly, since lymphoblasts and leuco- 
cytes were studied mRNA expression could be dimin- 
ished in the appropriate tissue or at a stage crucial to 
the development of the fragile X phenotype. 
No protein product has been identified as yet. An 
amino acid sequence has been deduced from the deter- 
mined nucleotide sequence. The sequence is very basic 
and contains a nuclear translocation signal suggesting 
a DNA-binding nuclear type protein; preliminary exper- 
iments with synthetic antibodies have shown a localiza- 
tion in the nucleus. It is still uncertain whether or not 
the CGG repeat is translated into the predicted polyar- 
ginine domain (Verkerk et al. 1991). 
Variation in the number of CGG repeats was found 
on normal X chromosomes with a range of from 6 to 
46 with a mean repeat number of 29; these normal alleles 
are stable during meiosis (Fu et al. 1991). A different 
number was reported by Kremer et al. (1991 a) but this 
was the result of a cloning artefact (Fu et al. 1991). No 
differences between ormal and fragile X chromosomes 
were found in the CGG flanking region. The variation 
in the length of DNA at the fragile site therefore appears 
to be restricted to changes within the CGG repeat. Af- 
fected males and females how large (500-5,000 bp) in- 
serts (Oberl6 et al. 1991; Yu et al. 1991) in the CGG 
repeat. The nature of the expansion cannot be deter- 
mined directly due to difficulties in cloning the expanded 
repeat region; the expansion is very CGG-rich suggest- 
ing that the insert is built up of CGG repeats. Normal 
transmitting males and their daughters show a premuta- 
tion with a small expansion. Premutation alleles range 
in size from 52 to 193 CGGs (Fu et al. 1991). The premu- 
tation alleles, in contrast o normal alleles, change in 
size with each meiotic transmission. It will be necessary 
to analyse a considerable number of alleles to establish 
whether the boundary between stable alleles (the largest 
allele 46) and unstable alleles (the smallest premutation 
allele 52) is really the cut-off point between ormal and 
premutation. 
The risk of expansion of the premutation allele is 
dependent on the size of the allele (Fu et al. 1991). The 
risk for a female of having a mentally retarded son de- 
pends on the size of her CGG repeat. If  the repeat 
number is low (5~70 CGGs) the risk of a large expan- 
sion is low; if the repeat number is high (above 90 
CGGs) the risk of expansion to a full mutation is 100%. 
This can explain the Sherman paradox: the risk that 
grandsons of normal transmitting males with be mental- 
ly retarded is 40% and not 50%. The mother of a normal 
transmitting male (with a low repeat number) has only 
a 9% risk of having a mentally retarded son. 
Diagnostics 
Scoring for the expansion has already proved to be a 
simple diagnostic test for the fragile X syndrome (Oberl~ 
et al. 1991 ; Yu et al. 1991 ; Rousseau et al. 1991b; Fu 
et al. 1991). Patients with a full mutation can be diag- 
nosed by Southern blot analysis (see Fig. 4). The insert 
size is always above 500 bp (Oberl6 et al. 1991 ; Fu et al. 
1991). In males a band of near normal size is sometimes 
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seen in addition to the diffuse band; the subject is then 
mentally retarded. An accurate prediction of mental re- 
tardation in female carriers is not possible. 
Premutation alleles can be studied by analysing the 
number of CGG repeats. The insert size ranges from 
50-500 bp. DNA analysis has not detected an expansion 
in a number of cases diagnosed previously as fragile 
X positive; this is most likely the result of misdiagnosis 
or the existence of a different fragile site (Rousseau et al. 
1991 b; Pieretti et al. 1991). 
The DNA test for the unstable region is very useful 
in testing carriers and for prenatal diagnosis (Hirst et al. 
1991c; Sutherland et al. 1991). If the prenatal test is 
carried out on chorionic villi special care has to be taken. 
In DNA of villi in contrast to fetal DNA no methylation 
of the CpG island in front of the CGG repeat was ob- 
served. Thus methylation cannot be used as a diagnostic 
test in villi. In patients a heterogeneous DNA pattern 
is often observed indicating a considerable somatic mu- 
tation rate. If the prenatal test is carried out on villi 
in a male pregnancy of a female carrier and a premuta- 
tion is detected this is not sufficient proof that the status 
of the mutation in the DNA of the villi is indicative 
of the mutation status in the fetus. More data from (re- 
trospective) tests are needed to solve this problem. 
The DNA diagnostic test can be used to screen sys- 
tematically population of men and women with (unex- 
plained) mental retardation. Before population screen- 
ing for carriers can be set up the cut-off points that 
distinguish between the repeat size of the normal allele, 
the premutation and the full mutation have to be deter- 
mined in more detail. The ethical implications of such 
a diagnosis hould also be examined. 
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Fig. 4. Southern blot analysis of 
EcoRI digested DNA of a frag- 
ile X family. Squares and circles 
represent male and female sub- 
jects, respectively. Open symbols 
indicate normal subjects; N no 
cytogenetic fragile X expression. 
Filled symbols represent subjects 
that are mentally retarded and 
show fragile X expression. Half- 
filled symbols indicate a subject 
who is normal but shows fragile 
X expression. Hybridization was 
performed with probe pP2 
(Fig. 2). n normal 5,2 kb band; 
a small insert of between 50 
and 500 bp; s smear of bands 
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Mechanism of mutation 
Since fully penetrant males rarely reproduce, a very high 
mutation rate (1/3,000) has been suggested to maintain 
the frequency of the disease (Brown 1990). The number 
of CGG repeats is highly polymorphic suggesting a high 
mutation rate. Direct testing of the DNA mutation has 
not revealed any new mutations. This is probably caused 
by a bias in selecting families with an affected member. 
This suggests that the transition of a (we)mutation to 
a full mutation most likely takes several generations. 
The transmission of a premutation over five generations 
has been noted (A. Smits, personal communication). A 
high mutation rate is seen in the premutation allele (Fu 
et al. 1991). Other high mutation rates have been re- 
ported in small repeats (Jeffreys et al. 1988). An explana- 
tion could be a pause or stop occurring during DNA 
replication at the CGG repeat, with subsequent slippage 
of the polymerase resulting in a change in the number 
of CGGs. Another mechanism is termination of replica- 
tion followed by reinitiation at an earlier CGG repeat. 
Oberl6 et al. (1991) have suggested that the mutation 
could be due to unequal sister chromatid exchange or 
to unequal meiotic crossing over. 
Normal transmitting males with an expanded CGG 
repeat never show methylation of the CpG island. Thus, 
the region is unstable before methylation takes place. 
It has been suggested that X inactivation (Laird 1987) 
is involved since the expansion of premutation to full 
mutation is never observed in daughters of transmitting 
males. I f  this chromosome is inactivated in the daughter 
as part of the process of dosage compensation, the reac- 
tivation of this chromosome is blocked in the fragile 
X region, Sutherland et al. (1991) have observed an ex- 
panded CGG repeat of the same full mutation size in 
both chorionic villi and fetal cells, while the methylation 
was limited to the fetal DNA. This suggests that first 
expansion has taken place and that the FMR-1 methyla- 
tion in the fragile X chromosome is acquired during 
fetal developmental in response to the expansion of the 
CGG repeat. 
Conclusion 
Rapid progress has been made in the analysis of the 
fragile X syndrome during 1991. Different groups have 
discovered that fragile X chromosomes are preferentially 
methylated. In these X chromosomes an insertion has 
been found in the methylated region. 
The FMR-1 gene, the transcription of which is shut 
off in patients, has been isolated. The expansion found 
in fragile X chromosomes is localized in the coding re- 
gion of the FMR-1 gene. The fragile X syndrome results 
from mutations in a (CGG)n repeat found in the coding 
region of the FMR- I  gene. It will be crucial to determine 
the FMR-1 protein product in order to learn more about 
the function of the gene. 
Diagnosis of the unstable region by DNA analysis 
is now available as an efficient and reliable test for the 
diagnosis of carriers, as well as for prenatal diagnosis. 
Acknowledgements. We are indebted to Bert Eussen and Jan van 
Hemel for performing the fluorescence in situ hybridization and 
to Cathy Bakker for helpful comments on the manuscript. 
References 
Bell MV, Hirst MC, Nakahori Y, MacKinnon RN, Roche A, Flint 
TJ, Tommerup N, Tranebjaerg L, Froster-Iskenius U, Kerr B, 
Turner G, Lindebaum D, Winter R, Pembrey M, Thibodeau 
S, Davies KE (1991) Physical mapping across the fragile X: 
Hypermethylation a d clinical expression of the fragile X syn- 
drome. Cell 64:861 866 
Brown WT (1990) The fragile X: progress towards solving the 
puzzle. Am J Hum Genet 47:175-180 
Brown WT, Gross AC, Chan C, Jenkins EC (1985) Genetic linkage 
heterogeneity in the fragile X syndrome. Hum Genet 78:71:11- 
18 
Brown WT, Gross AC, Chan C, Jenkins EC, Mandel J-L, Oberl~ 
I, Arveiler B, Novelli G, Thibodeau S, Hagerman R, Summers 
K, Turner G, White BN, Mulligan L, Forster-Gibson C,Holden 
JJA, Zoll B, Krawzak M, Gonnewardena P, Gustavson KH, 
Petterson U, Holmgren C, Schwartz C, Howard-Peebles PN, 
Murphy P, Breg WR, Veenema H, Carperter NJ (1988) Multilo- 
cus analysis of the fragile X syndrome. Hum Genet 78:201-205 
Camerino G, Mattei MG, Mattei JF, Jaye M, Mandel JL (1983) 
Close mapping of fragile X mental retardation syndrome to 
haemophilia B and transmission through a normal male. Na- 
ture 306 :701-704 
Dahl N, Goonewardena P, Malmgren H, Gustavson KH, Holm- 
gren G, Seemanowa E, Anneren G, Flood A, Pettersson U
(1989) Linkage analysis of families with fragile X mental retar- 
dation using a novel RFLP marker (DXS304). Am J Hum Gen- 
et 45 : 304-309 
Djabali M, Nguyen C, Biunno I, Oostra BA, Mattei M-G, Ikeda 
J-E, Jordan BR (1991) Laser microdissection f the fragile X 
region: identification of cosmid clones and of conserved se- 
quences inthis region. Genomics 10:1053-1060 
Fish GS, Arinami T, Froster-Iskenius U, Fryns JP, Curfs LM, 
Borggraef M, Howard-Peebles PN, Schwartz CE, Simensen R J, 
Shapiro LR (1991) Relationship between age and IQ among 
fragile X males: a multicenter study. Am J Med Genet 38:481- 
487 
Fu Y-H, Kuhl DPA, Pizzuti A, Pieretti M, Sutcliffe J, Richards 
S, Verkerk AJMH, Holden JJA, Fenwick RG, Warren ST, Oos- 
tra BA, Nelson DL, Caskey CT (1991) Variation of the CGG 
repeat at the fragile X site results in genetic instability: resolu- 
tion of the Sherman paradox. Cell 67:1047-1058 
Gustavson KH, Blomquist H, Hotmgren G (1986) Prevalence of 
fragile X syndrome in mentally retarded children in a Swedish 
county. Am J Hum Genet 23:581-588 
Heitz D, Rousseau F, Devys D, Saccone S, Abderrahim H, Le 
Paslier D, Cohen D, Vincent A, Toniolo D, Della Valle G, 
Johson S, Schlessinger D, Oberl~ I, Mandel JL (1991) Isolation 
of sequences that span the fragile X and identification of a 
fragile X-related CpG island. Science 251 :I 236-1239 
Hirst HC, Roche A, Flint TJ, Mackinnon RN, Bassett JHD, Naka- 
hori Y, Watson JE, Bell MV, Patterson MN, Boyd Y, Thomas 
NST, Knight SJL, Warren ST, Hors-Cayla M, Schmidt M, Da- 
vies KE (1991a) Linear order of new established markers 
around the fragile site at Xq27.3. Genomics 10:243-249 
Hirst MC, Rack K, Makahori Y, Roche A, Bell MV, Flynn G, 
Christadoulou Z, Mackinnon RN, Francis M, Littler AJ, An- 
and R, Poustka A-M, Lehrach H, Schlessinger D, D'Urso M, 
Buckle VJ, Davies KE (1991 b) A YAC contig across the fragile 
X site defines the region of fragility. Nucleic Acids Res 
19: 3283-3288 
Hirst MC, Knight S, Davies K, Cross G, Ocraft K, Raeburn S, 
Heeger S, Eunpu D, Jenkins EC, Lindenbaum R (1991 c) Prena- 
tal diagnosis of fragile X syndrome. Lancet 338 :956-957 
387 
Hulsebos ThJM, Oostra BA, Broersen S, van Oost BA, Westerveld 
A (1991) New distal marker closely linked to the fragile X 
locus. Hum Genet 87:369-372 
Jacky PB, Ahuja YR, Anyane-Yeboa K, Breg WR, Carpenter NJ, 
Froster-Iskenius UG, Fryns JP, Glover TW, Gustavson KH, 
Hoegerman SF, Holmgren G, Howard-Peebles PN, Jenkins EC, 
Krawczun M, Neri G, Pettigrew A, Schaap T, Schonber SA, 
Shapiro LR, Spinner N, Steinbach P, Vianna-Morgante AM, 
Watson MS, Wilmot PL (1991) Guidelines for the preparation 
and analysis of the fragile X chromosome in lymphocytes. Am 
J Med Genet 38:400-403 
Jeffreys AJ, Roule NJ, Wilson V, Wong Z (1988) Spontaneous 
mutation rates to new length alleles at tandem-repetitive hyper- 
variable loci in human DNA. Nature 332:278 281 
Kremer E J, Yu S, Pritchard M, Nagaraja R, Heitz D, Lynch M, 
Baker E, Hyland VJ, Little RD, Wada M, Toniolo D, Vincent 
A, Rousseau F, Schlessinger D, Sutherland G, Richards RI 
(1991 a) Isolation of a human DNA sequence which spans the 
fragile X. Am J Hum Genet 49:65(~661 
Kremer EJ, Pritchard M, Lynch M, Yu S, Holman K, Baker E, 
Warren ST, Schlessinger D, Sutherland GR, Richards RI 
(1991 b) Mapping of DNA instability at the fragile X to a trin- 
ucleotide repeat sequence p(CCG)n. Science 252:1711-1714 
Laird CD (1987) Proposed mechanism of inheritance and expres- 
sion of the human fragile-X syndrome of mental retardation. 
Genetics 117 :582599 
Lubs HA (1969) A marker X-chromosome. Am J Hum Genet 
21 : 231-244 
Mackinnon RN, Hirst MC, Bell MV, Watson JEV, Claussen U, 
Ludecke HJ, Senger G, Hortshemke B, Davies KE (1990) Mi- 
crodissection of the fragile X region. Am J Hum Genet 47 : 181- 
187 
Martin JP, Bell J (1943) A pedigree of mental defect showing sex- 
linkage. J Neurol Psych 6:154-157 
Nielsen KB, Tommerup N, Poulsen H, Jacobsen P, Beck B, Mikkel- 
sen M (1983) Carrier detection and X inactivation studies in 
the fragile X syndrome. Cytogenetic studies in 63 obligate and 
potential carriers of the fragile X. Hum Genet 64: 240-245 
Oberl6 I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, 
Bou6 J, Bertheas MF, Mandel JF (1991) Instability of a 550- 
base pair DNA segment and abnormal methylation i fragile 
X syndrome. Science 252:1097-1102 
Oostra BA, Hupkes PE, Perdon LF, van Bennekom CA, Bakker 
E, Halley DJJ, Schmidt M, Du Sart D, Smits A, Wieringa 
B, van Oost BA (1990) New polymorphic DNA marker close 
to the fragile site FRAXA. Genomics 6:129-132 
Opitz JM, Sutherland GR (1984) Conference report: International 
workshop on the fragile X and X-linked mental retardation. 
Am J Med Genet 17 : 5 94 
Pembrey ME, Winter RM, Davies KE (1985) A premutation that 
generates a defect at crossing over explains the inheritance of
Fragile X mental retardation. Am J Med Genet 21:709-717 
Pieretti M, Zhang F, Fu Y-H, Warren ST, Oostra BA, Caskey 
CT, Nelson DL (1991) Absence of expression of the FMR-1 
gene in fi'agile X syndrome. Cell 66:817-822 
Poustka A, Dietrich A, Langenstein G, Toniolo D, Warren ST, 
Lehrach H ( 1991) Physical map of human Xq27-qter: localizing 
the region of the fragile X mutation. Proc Natl Acad Sci USA 
88 : 830~8306 
Riggins GJ, Sherman SL, Oostra BA, Feitell D, Sutcliffe JS, Nelson 
DL, van Oost BA, Smits APT, Kuhl D, Caskey CT, Warren 
ST (1992) Characterization f a highly polymorphic dinucleo- 
tide repeat 150 kb proximal to the fragile site. Am J Med Genet, 
in press 
Rousseau F, Vincent A, Rivella S, Heitz D, Tribioli C, Maestrini 
E, Warren ST, Suthers GK, Goodfellow P, Mandel JL, Toniolo 
D, Oberl6 I (1991a) Four chromosomal breakpoints and four 
new probes mark out a 10cM region encompassing the 
FRAXA locus. Am J Hum Genet 48:108 116 
Rousseau F, Heitz D, Biancalana V, Blumenfeld S, Kretz C, Bouh 
J, Tommerup N, van der Hagen C, DeLozier-Blanchet C, Cro- 
quette M-F, Gilgenkrantz S, Jalbert P, Voelckel M-A, Oberl6 
I, Mandel J-L (199b) Direct diagnosis by DNA analysis of 
the fragile X syndrome of mental retardation. New Engl J Med 
325 :1673-1681 
Sherman SL, Jacobs PA, Morton NE, Froster-Iskenius U, Howard- 
Peebles PN, Nielsen KB, Partington NW, Sutherland GR, 
Turner G, Watson M (1985) Further segregation of the fragile 
X syndrome with special reference to transmitting males. Hum 
Genet 69 : 3289-3299 
Sutherland GR (1977) Fragile sites on human chromosome: dem- 
onstration of their dependence on the type of tissue culture 
medium. Science J97:265-266 
Sutherland GR, Baker E (1986) Effects of nudeotides on expres- 
sion of the folate sensitive fragile site. Am J Med Genet 23:409- 
417 
Sutherland GR, Hecht F (1985) Fragile sites on human chromo- 
somes. Oxford University Press, New York, pp 113-131 
Sutherland GR, Ledbetter DH (1989) Report of the committee 
on cytogenetic markers. Cytogenet Cell Genet 51:452~458 
Sutherland GR, Gedeon A, Kornman L, Donnelly A, Byard RW, 
Mulley JC, Kremer E, Lynch M, Pritchard M, Yu S, Richards 
RI (1991) Prenatal diagnosis of fragile X syndrome by direct 
detection of the unstable DNA sequence. N Engl J Med 
325:1720-1722 
Suthers GK, Callen CF, Hyland VJ, Kozman HM, Baker E, Eyre 
H, Harper PS, Roberts SH, Hors-Cayla MC, Davies KE, Bell 
MV, Sutherland GR (1989) A new DNA marker tightly linked 
to the fi'agile X locus (FRAXA). Science 246:1298-1300 
Suthers GK, Mulley JC, Voelckel MA, Dahl N, Vaisanen ML, 
Steinbach P, Glass IA, Schwartz CE, van Oost BA, Thibodeau 
SN, Haites NE, Oostra BA, Schinzel A, Carballo M, Morris 
CP, Hopwood JJ, Sutherland GF (1991 a) Linkage homogeneity 
near the fragile X locus in normal and fragile X families. Geno- 
mics 10:576582 
Suthers GK, Mulley JC, Voelckel MA, Dahl N, Vaisanen ML, 
Steinbach P, Glass IA, Schwartz CE, van Oost BA, Thibodeau 
SN, Haites NE, Oostra BA, Gin+ R, Carballo M, Morris CP, 
Hopwood JJ, Sutherland GR (1991 b) Genetic mapping of new 
DNA probes at Xq27 defines a strategy for DNA studies in 
the fragile X syndrome. Am J Hum Genet 48 : 460-467 
Verkerk AJMH, Pieretti M, Sutcliffe JS, Fu Y, Kuhl DPA, Pizzuti 
A, Reiner O, Richards S, Victoria MF, Zhang F, Eussen BE, 
van Ommen G-JB, Blonden LAJ, Riggins G J, Chastain JL, 
Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA, 
Warren ST (1991) Identification ofa gene (FMR-I) containing 
a CGG repeat coincident with a fragile X breakpoint duster 
region exhibiting length variation in fragile X syndrome. Cell 
65 : 905-914 
Verkerk AJHM, Eussen EHJ, van Hemel JO, Oostra BA (1992) 
The limited size of the fragile site shown by fluorescence in 
situ hybridization. Am J Med Genet (in press) 
Vincent A, Heitz D, Petit C, Kretz C, Oberl6 I, Mandel JF (1991) 
Abnormal pattern detected in fragile X patients by pulse-field 
gel electrophoresis. Nature 349:624-626 
Warren ST, Zhang F, Licamelli GR, Peters JF (1987) The fragile 
X site in somatic ell hybrids: an approach for molecular clon- 
ing of fragile sites. Science 237:420-423 
Webb TP, Bundey SE, Thake AI, Todd J (1986) Population inci- 
dence and segregation ratios in the Martin-Bell syndrome. Am 
J Med Genet 23 : 573-580 
Yu S, Pritchard M, Kremer E, Lynch M, Nancarrow J, Baker 
E, Holman K, Mulley JC, Warren ST, Schlessinger D, Suther- 
land GR, Richards RI (1991) Fragile X genotype characterized 
by an unstable region of DNA. Science 252:1179-1181 
